117 related articles for article (PubMed ID: 29311472)
1. Advances in Studies of P-Glycoprotein and Its Expression Regulators.
Yano K; Tomono T; Ogihara T
Biol Pharm Bull; 2018; 41(1):11-19. PubMed ID: 29311472
[TBL] [Abstract][Full Text] [Related]
2. Drug resistance via radixin-mediated increase of P-glycoprotein membrane expression during SNAI1-induced epithelial-mesenchymal transition in HepG2 cells.
Kamioka H; Edaki K; Kasahara H; Tomono T; Yano K; Ogihara T
J Pharm Pharmacol; 2021 Dec; 73(12):1609-1616. PubMed ID: 34313784
[TBL] [Abstract][Full Text] [Related]
3. Different regulation of P-glycoprotein function between Caco-2 and Caki-1 cells by ezrin, radixin and moesin proteins.
Yano K; Otsuka K; Kato Y; Kawabata H; Ohmori S; Arakawa H; Ogihara T
J Pharm Pharmacol; 2016 Mar; 68(3):361-7. PubMed ID: 26888084
[TBL] [Abstract][Full Text] [Related]
4. Blood-brain barrier (BBB) pharmacoproteomics: reconstruction of in vivo brain distribution of 11 P-glycoprotein substrates based on the BBB transporter protein concentration, in vitro intrinsic transport activity, and unbound fraction in plasma and brain in mice.
Uchida Y; Ohtsuki S; Kamiie J; Terasaki T
J Pharmacol Exp Ther; 2011 Nov; 339(2):579-88. PubMed ID: 21828264
[TBL] [Abstract][Full Text] [Related]
5. Moesin-Mediated P-Glycoprotein Activation During Snail-Induced Epithelial-Mesenchymal Transition in Lung Cancer Cells.
Kamioka H; Tomono T; Fujita A; Onozato R; Iijima M; Tsuchida S; Arai T; Fujita Y; Zhang X; Yano K; Ogihara T
J Pharm Sci; 2020 Jul; 109(7):2302-2308. PubMed ID: 32173323
[TBL] [Abstract][Full Text] [Related]
6. Contribution of radixin to P-glycoprotein expression and transport activity in mouse small intestine in vivo.
Yano K; Tomono T; Sakai R; Kano T; Morimoto K; Kato Y; Ogihara T
J Pharm Sci; 2013 Aug; 102(8):2875-81. PubMed ID: 23754525
[TBL] [Abstract][Full Text] [Related]
7. Involvement of moesin in the development of morphine analgesic tolerance through P-glycoprotein at the blood-brain barrier.
Kobori T; Fujiwara S; Miyagi K; Harada S; Nakamoto K; Nakagawa T; Takahashi H; Narita M; Tokuyama S
Drug Metab Pharmacokinet; 2014; 29(6):482-9. PubMed ID: 25048710
[TBL] [Abstract][Full Text] [Related]
8. ABC transporters during epilepsy and mechanisms underlying multidrug resistance in refractory epilepsy.
Lazarowski A; Czornyj L; Lubienieki F; Girardi E; Vazquez S; D'Giano C
Epilepsia; 2007; 48 Suppl 5():140-9. PubMed ID: 17910594
[TBL] [Abstract][Full Text] [Related]
9. Radixin influences the changes in the small intestinal P-glycoprotein by etoposide treatment.
Kobori T; Harada S; Nakamoto K; Tokuyama S
Biol Pharm Bull; 2013; 36(11):1822-8. PubMed ID: 24189426
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of drug efflux transporter liabilities of darifenacin in cell culture models of the blood-brain and blood-ocular barriers.
Miller DW; Hinton M; Chen F
Neurourol Urodyn; 2011 Nov; 30(8):1633-8. PubMed ID: 21826715
[TBL] [Abstract][Full Text] [Related]
11. The role of P-glycoprotein in intestinal transport versus the BBB transport of tetraphenylphosphonium.
Swed A; Eyal S; Madar I; Zohar-Kontante H; Weiss L; Hoffman A
Mol Pharm; 2009; 6(6):1883-90. PubMed ID: 19722701
[TBL] [Abstract][Full Text] [Related]
12. Induction of P-glycoprotein and Bcrp at the rat blood-brain barrier following a subchronic morphine treatment is mediated through NMDA/COX-2 activation.
Yousif S; Chaves C; Potin S; Margaill I; Scherrmann JM; Declèves X
J Neurochem; 2012 Nov; 123(4):491-503. PubMed ID: 22845665
[TBL] [Abstract][Full Text] [Related]
13. Glutamate up-regulates P-glycoprotein expression in rat brain microvessel endothelial cells by an NMDA receptor-mediated mechanism.
Zhu HJ; Liu GQ
Life Sci; 2004 Jul; 75(11):1313-22. PubMed ID: 15234189
[TBL] [Abstract][Full Text] [Related]
14. Effect of knockdown of ezrin, radixin, and moesin on P-glycoprotein function in HepG2 cells.
Kano T; Wada S; Morimoto K; Kato Y; Ogihara T
J Pharm Sci; 2011 Dec; 100(12):5308-14. PubMed ID: 21837648
[TBL] [Abstract][Full Text] [Related]
15. P-glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution.
Shaik N; Giri N; Pan G; Elmquist WF
Drug Metab Dispos; 2007 Nov; 35(11):2076-85. PubMed ID: 17709369
[TBL] [Abstract][Full Text] [Related]
16. Kinetic analysis of the cooperation of P-glycoprotein (P-gp/Abcb1) and breast cancer resistance protein (Bcrp/Abcg2) in limiting the brain and testis penetration of erlotinib, flavopiridol, and mitoxantrone.
Kodaira H; Kusuhara H; Ushiki J; Fuse E; Sugiyama Y
J Pharmacol Exp Ther; 2010 Jun; 333(3):788-96. PubMed ID: 20304939
[TBL] [Abstract][Full Text] [Related]
17. [Role of Scaffold Proteins in Functional Alteration of Small Intestinal P-glycoprotein by Anti-cancer Drugs].
Kobori T; Harada S; Nakamoto K; Tokuyama S
Yakugaku Zasshi; 2015; 135(5):687-95. PubMed ID: 25948303
[TBL] [Abstract][Full Text] [Related]
18. Involvement of PtdIns(4,5)P2 in the regulatory mechanism of small intestinal P-glycoprotein expression.
Kobori T; Harada S; Nakamoto K; Tokuyama S
J Pharm Sci; 2014 Feb; 103(2):743-51. PubMed ID: 24311454
[TBL] [Abstract][Full Text] [Related]
19. The role of ATP binding cassette transporters in tissue defense and organ regeneration.
Huls M; Russel FG; Masereeuw R
J Pharmacol Exp Ther; 2009 Jan; 328(1):3-9. PubMed ID: 18791064
[TBL] [Abstract][Full Text] [Related]
20. Genetic deletion of P-glycoprotein alters stress responsivity and increases depression-like behavior, social withdrawal and microglial activation in the hippocampus of female mice.
Brzozowska NI; Smith KL; Zhou C; Waters PM; Cavalcante LM; Abelev SV; Kuligowski M; Clarke DJ; Todd SM; Arnold JC
Brain Behav Immun; 2017 Oct; 65():251-261. PubMed ID: 28502879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
